Here, we have designed and created a TM, based on a CD10 mAb, and provided proof of concept for the efficient targeting of a CD10-expressing B-ALL cell line, as well as patient-isolated ALL blasts using the UniCAR system. Here, MME is linked to acute lymphoblastic leukemia.